Literature DB >> 3479417

Susceptibility of urinary isolates of Corynebacterium group D2 to fifteen antimicrobials and acetohydroxamic acid.

F Soriano1, C Ponte, M Santamaría, A Torres, R Fernández-Roblas.   

Abstract

The susceptibility in vitro of 28 Corynebacterium group D2 strains, mainly isolated from urine, to fifteen antimicrobial agents and acetohydroxamic acid (AHA) was determined at two pH values. The bactericidal activity of four antimicrobials and AHA was studied in three reference strains in broth at two pHs and with two inoculum sizes. The activity of norfloxacin and AHA, against one selected strain, in broth and human urine, was also determined. Vancomycin, ofloxacin and norfloxacin were the most active agents tested. Norfloxacin acted bactericidally in broth and in human urine but was not synergic with AHA.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3479417     DOI: 10.1093/jac/20.3.349

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  19 in total

1.  A case of urinary tract infection caused by Corynebacterium urealyticum and coryneform group F1.

Authors:  F Soriano; C Ponte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

Review 2.  Coryneform bacteria in infectious diseases: clinical and laboratory aspects.

Authors:  M B Coyle; B A Lipsky
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

3.  In vitro susceptibility of Corynebacterium group D2 and Corynebacterium jeikeium to twelve antibiotics.

Authors:  A Philippon; F Bimet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-12       Impact factor: 3.267

4.  In vitro activity of 79 antimicrobial agents against Corynebacterium group D2.

Authors:  J A García-Rodriguez; J E García Sánchez; J L Muñoz Bellido; T Nebreda Mayoral; E García Sánchez; I García García
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

5.  Antimicrobial susceptibility pattern of Corynebacterium striatum.

Authors:  L Martínez-Martínez; A Pascual; K Bernard; A I Suárez
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

6.  Skin colonization by Corynebacterium groups D2 and JK in hospitalized patients.

Authors:  F Soriano; J L Rodriguez-Tudela; R Fernández-Roblas; J M Aguado; M Santamaría
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

7.  Comparison of E-test with broth microdilution and disk diffusion for susceptibility testing of coryneform bacteria.

Authors:  L Martínez-Martínez; M C Ortega; A I Suárez
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

8.  Comparative in vitro activities of new quinolones against coryneform bacteria.

Authors:  L Martínez-Martínez; A I Suárez; M C Ortega; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

9.  Urinary tract infection with Corynebacterium urealyticum in South Africa.

Authors:  D Walkden; K P Klugman; S Vally; P Naidoo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-01       Impact factor: 3.267

10.  In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against Coryneform bacteria.

Authors:  L Martínez-Martínez; A Pascual; A I Suárez; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.